N Verses Capital, LLC Royalty Pharma PLC Call Options Transaction History
N Verses Capital, LLC
- $219 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RPRX
# of Institutions
403Shares Held
285MCall Options Held
305KPut Options Held
138K-
Morgan Stanley New York, NY44.1MShares$1.16 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA38MShares$997 Million0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$603 Million0.01% of portfolio
-
Baillie Gifford & CO16.1MShares$423 Million0.35% of portfolio
-
Viking Global Investors LP12MShares$314 Million1.26% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11.5B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...